These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19160220)

  • 61. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center.
    Kim JW; Kim I; Oh KH; Yoon SS; Oh MD; Song YW; Heo DS; Bang YJ; Han KS; Han JS; Park S; Kim BK
    Hematology; 2011 Mar; 16(2):73-9. PubMed ID: 21418736
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma.
    George JN; Li X; McMinn JR; Terrell DR; Vesely SK; Selby GB
    Transfusion; 2004 Feb; 44(2):294-304. PubMed ID: 14962323
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
    Clark WF
    Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Re-examination of 30-day survival and relapse rates in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    Bittencourt CE; Ha JP; Maitta RW
    PLoS One; 2015; 10(5):e0127744. PubMed ID: 26000799
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y; Fujita T
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation.
    Sarode R; McFarland JG; Flomenberg N; Casper JT; Cohen EP; Drobyski WR; Ash RC; Horowitz MM; Camitta B; Lawton C
    Bone Marrow Transplant; 1995 Aug; 16(2):271-5. PubMed ID: 7581147
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli.
    Nakayama S; Hirashio S; Yorishima H; Doi T; Yoshida Y; Matsumoto M; Masaki T
    CEN Case Rep; 2019 Nov; 8(4):266-270. PubMed ID: 31177384
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome.
    Rizvi MA; Vesely SK; George JN; Chandler L; Duvall D; Smith JW; Gilcher RO
    Transfusion; 2000 Aug; 40(8):896-901. PubMed ID: 10960513
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Elliott MA; Nichols WL
    Mayo Clin Proc; 2001 Nov; 76(11):1154-62. PubMed ID: 11702904
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inefficacy of intravenous immunoglobulin in patients with low-risk thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome.
    Finazzi G; Bellavita P; Falanga A; Viero P; Barbui T
    Am J Hematol; 1992 Nov; 41(3):165-9. PubMed ID: 1415190
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura.
    Alvarez-Larrán A; Del Río J; Ramírez C; Albo C; Peña F; Campos A; Cid J; Muncunill J; Sastre JL; Sanz C; Pereira A
    Vox Sang; 2004 May; 86(4):246-51. PubMed ID: 15144529
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment of postpartum thrombotic microangiopathy with plasma exchange using cryosupernatant as replacement.
    Lampinen K; Peltonen S; Pettilä V; Kaaja R
    Acta Obstet Gynecol Scand; 2004 Feb; 83(2):175-9. PubMed ID: 14756736
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM; Habashy D; Craig JC
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003594. PubMed ID: 16625586
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunosuppressive agents for treating IgA nephropathy.
    Vecchio M; Bonerba B; Palmer SC; Craig JC; Ruospo M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2015 Aug; (8):CD003965. PubMed ID: 26235292
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Familial, recurring plasma infusion dependent thrombotic thrombocytopenic purpura/hemolytic uremic syndrome].
    Litwin M; Smirska E
    Pol Merkur Lekarski; 2000 Apr; 8(46):289-90. PubMed ID: 10897656
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Syndromes of Thrombotic Microangiopathy.
    Shatzel JJ; Taylor JA
    Med Clin North Am; 2017 Mar; 101(2):395-415. PubMed ID: 28189178
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Haemolytic uremic syndrome: diagnosis and management.
    Sheerin NS; Glover E
    F1000Res; 2019; 8():. PubMed ID: 31598213
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2010 Nov; (11):CD003594. PubMed ID: 21069676
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Thrombotic microangiopathies.
    Rosove MH
    Semin Arthritis Rheum; 2014 Jun; 43(6):797-805. PubMed ID: 24360024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.